STTK

SHATTUCK LABS INC

STTK·82024L103·US·Common Stock·Healthcare - Biotechnology-Activist

STTK (SHATTUCK LABS INC) is held by 55 institutional investors as of Q1 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($29.9M), VANGUARD CAPITAL MANAGEMENT LLC ($14.6M), PRICE T ROWE ASSOCIATES INC /MD/ ($11.5M). Net institutional sentiment: Bullish.

55
Holders
Avg rating(9 Elite)
$131.5M
Total Value
77% (56)
Fund Consensus
41 buying - 12 selling
STTKSmart Money Verdict
View all
Held by 55 funds
9 elite
Who's Trading
ActivistDTDeep Track Capital, LP5.2%Jun 17, 2026
ActivistOAORBIMED ADVISORS LLC10.0%Jun 15, 2026
ActivistRERedmile Group, LLC9.9%Jun 11, 2026
ActivistTRT. Rowe Price Investment Management, Inc.13.8%May 15, 2026
InsiderSAShukla Abhinav A.Sell $14KMay 12, 2026
InsiderSTSchreiber TaylorVest 26K shMay 12, 2026
InsiderSSStout StephenTax 968 shMay 10, 2026
ActivistPRProsight Management, LP9.9%Nov 13, 2025
ActivistOAORBIMED ADVISORS LLC10.0%Sep 2, 2025
InsiderAMAshiya MonaBuy $4.6MAug 25, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
4.6M(-26.3%)$29.9M0.0%+62.03%
0
New
2.3M$14.6M0.0%+56.97%
39
Decreased
1.8M(-7.4%)$11.5M0.0%+84.44%
0
Increased
1.2M(+118.3%)$7.5M0.0%+73.24%
44
Decreased
1M(-3.5%)$6.6M0.0%+84.44%
0
Increased
905,707(+7775.7%)$5.8M0.0%+57.27%
44
Increased
763,745(+60.0%)$4.9M0.0%+134.22%
39
Increased
715,965(+382.4%)$4.6M0.0%+70.13%
43
Increased
645,705(+4.4%)$4.2M0.0%-38.76%
28
Increased
604,500(+77.4%)$3.9M0.0%+86.27%
41
Increased
581,471(+18.7%)$3.7M0.0%+157.50%
31
Increased
510,806(+22.1%)$3.3M0.0%+277.87%
32
Increased
415,938(+669.6%)$2.7M0.0%+73.35%
42
Decreased
392,500(-0.0%)$2.5M0.0%+85.54%
0
Increased
382,648(+52.4%)$2.5M0.0%+73.97%
37
New
324,588$2.1M0.0%+56.97%
36
Decreased
316,012(-27.8%)$2M0.0%+112.71%
0
Increased
263,768(+22.4%)$1.7M0.0%+55.22%
31
New
228,817$1.5M0.0%+56.97%
35
Increased
200,136(+1005.2%)$1.3M0.0%+58.30%
41

Showing 1-20 of 56

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used